Works matching AU Steg, Ph. Gabriel

Results: 60
    1
    2

    Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.

    Published in:
    European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. e75, doi. 10.1093/eurjpc/zwae110
    By:
    • Szarek, Michael;
    • Reijnders, Esther;
    • Steg, Ph Gabriel;
    • Jukema, J Wouter;
    • Schwertfeger, Markus;
    • Bhatt, Deepak L;
    • Bittner, Vera A;
    • Diaz, Rafael;
    • Fazio, Sergio;
    • Garon, Genevieve;
    • Goodman, Shaun G;
    • Harrington, Robert A;
    • White, Harvey D;
    • Zeiher, Andreas M;
    • Cobbaert, Christa;
    • Schwartz, Gregory G
    Publication type:
    Article
    3
    4
    5

    Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEYOUTCOMES trial.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 33, doi. 10.1177/2047487320941987
    By:
    • Diaz, Rafael;
    • Li, Qian H.;
    • Bhatt, Deepak L.;
    • Bittner, Vera A.;
    • Baccara-Dinet, Marie T.;
    • Goodman, Shaun G.;
    • Jukema, J. Wouter;
    • Takeshi Kimura;
    • Parkhomenko, Alexander;
    • Pordy, Robert;
    • Reiner;, Željko;
    • Roe, Matthew T.;
    • Szarek, Michael;
    • Hung-Fat Tse;
    • White, Harvey D.;
    • Zahger, Doron;
    • Zeiher, Andreas M.;
    • Schwartz, Gregory G.;
    • Steg, Ph Gabriel
    Publication type:
    Article
    6
    7
    8

    Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.

    Published in:
    2021
    By:
    • Szarek, Michael;
    • Bhatt, Deepak L.;
    • Steg, Ph. Gabriel;
    • Cannon, Christopher P.;
    • Leiter, Lawrence A.;
    • McGuire, Darren K.;
    • Lewis, Julia B.;
    • Riddle, Matthew C.;
    • Voors, Adriaan A.;
    • Metra, Marco;
    • Lund, Lars H.;
    • Komajda, Michel;
    • Testani, Jeffrey M.;
    • Wilcox, Christopher S.;
    • Ponikowski, Piotr;
    • Lopes, Renato D.;
    • Banks, Phillip;
    • Tesfaye, Eshetu;
    • Ezekowitz, Justin A.;
    • Verma, Subodh
    Publication type:
    journal article
    9
    10
    11
    12

    Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.

    Published in:
    European Heart Journal, 2015, v. 36, n. 29, p. 1901, doi. 10.1093/eurheartj/ehv116
    By:
    • Varenhorst, Christoph;
    • Eriksson, Niclas;
    • Johansson, A° sa;
    • Barratt, Bryan J.;
    • Hagström, Emil;
    • kerblom, Axel A°;
    • Syvänen, Ann-Christine;
    • Becker, Richard C.;
    • James, Stefan K.;
    • Katus, Hugo A.;
    • Husted, Steen;
    • Steg, Ph. Gabriel;
    • Siegbahn, Agneta;
    • Voora, Deepak;
    • Teng, Renli;
    • Storey, Robert F.;
    • Wallentin, Lars
    Publication type:
    Article
    13
    14
    15

    Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 40, p. 2812
    By:
    • Wijns, William;
    • Steg, Ph. Gabriel;
    • Mauri, Laura;
    • Kurowski, Volkhard;
    • Parikh, Keyur;
    • Gao, Runlin;
    • Bode, Christoph;
    • Greenwood, John P.;
    • Lipsic, Erik;
    • Alamgir, Farqad;
    • Rademaker-Havinga, Tessa;
    • Boersma, Eric;
    • Radke, Peter;
    • van Leeuwen, Frank;
    • Camenzind, Edoardo
    Publication type:
    Article
    16
    17

    The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.

    Published in:
    European Heart Journal, 2014, v. 35, n. 23, p. 1541
    By:
    • Husted, Steen;
    • James, Stefan K.;
    • Bach, Richard G.;
    • Becker, Richard C.;
    • Budaj, Andrzej;
    • Heras, Magda;
    • Himmelmann, Anders;
    • Horrow, Jay;
    • Katus, Hugo A.;
    • Lassila, Riita;
    • Morais, Joao;
    • Nicolau, José C.;
    • Steg, Ph. Gabriel;
    • Storey, Robert F.;
    • Wojdyla, Daniel;
    • Wallentin, Lars
    Publication type:
    Article
    18

    ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

    Published in:
    European Heart Journal, 2012, v. 33, n. 20, p. 2569
    By:
    • Steg, Ph. Gabriel;
    • James, Stefan K.;
    • Atar, Dan;
    • Badano, Luigi P.;
    • Lundqvist, Carina Blomstrom;
    • Borger, Michael A.;
    • Di Mario, Carlo;
    • Dickstein, Kenneth;
    • Ducrocq, Gregory;
    • Fernandez-Aviles, Francisco;
    • Gershlick, Anthony H.;
    • Giannuzzi, Pantaleo;
    • Halvorsen, Sigrun;
    • Huber, Kurt;
    • Juni, Peter;
    • Kastrati, Adnan;
    • Knuuti, Juhani;
    • Lenzen, Mattie J.;
    • Mahaffey, Kenneth W.;
    • Valgimigli, Marco
    Publication type:
    Article
    19
    20

    The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.

    Published in:
    European Heart Journal, 2012, v. 33, n. 17, p. 2143
    By:
    • Bhatt, Deepak L.;
    • Paré, Guillaume;
    • Eikelboom, John W.;
    • Simonsen, Katy L.;
    • Emison, Eileen S.;
    • Fox, Keith A.A.;
    • Steg, Ph. Gabriel;
    • Montalescot, Gilles;
    • Bhakta, Nihar;
    • Hacke, Werner;
    • Flather, Marcus D.;
    • Mak, Koon-Hou;
    • Cacoub, Patrice;
    • Creager, Mark A.;
    • Berger, Peter B.;
    • Steinhubl, Steven R.;
    • Murugesan, Gurunathan;
    • Mehta, Shamir R.;
    • Kottke-Marchant, Kandice;
    • Lincoff, A. Michael
    Publication type:
    Article
    21
    22
    23
    24

    Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.

    Published in:
    European Heart Journal, 2024, v. 45, n. 47, p. 5023, doi. 10.1093/eurheartj/ehae614
    By:
    • Gibson, C Michael;
    • Duffy, Danielle;
    • Bahit, Maria Cecilia;
    • Chi, Gerald;
    • White, Harvey;
    • Korjian, Serge;
    • Alexander, John H;
    • Lincoff, A Michael;
    • Heise, Mark;
    • Kingwell, Bronwyn A;
    • Nicolau, Jose C;
    • Lopes, Renato D;
    • Cornel, Jan H;
    • Lewis, Basil S;
    • Vinereanu, Dragos;
    • Goodman, Shaun G;
    • Bode, Christoph;
    • Steg, Ph Gabriel;
    • Libby, Peter;
    • Sacks, Frank M
    Publication type:
    Article
    25

    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.

    Published in:
    European Heart Journal, 2024, v. 45, n. 13, p. 1173, doi. 10.1093/eurheartj/ehad889
    By:
    • Sayah, Neila;
    • Bhatt, Deepak L;
    • Miller, Michael;
    • Brinton, Eliot A;
    • Jacobson, Terry A;
    • Ketchum, Steven B;
    • Jiao, Lixia;
    • Pineda, Armando Lira;
    • Doyle, Ralph T;
    • Tardif, Jean Claude;
    • Ballantyne, Christie M;
    • Steg, Ph Gabriel
    Publication type:
    Article
    26
    27
    28

    Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial.

    Published in:
    Diabetes Care, 2015, v. 38, n. 4, p. 696, doi. 10.2337/dc14-1850
    By:
    • Udell, Jacob A.;
    • Bhatt, Deepak L.;
    • Braunwald, Eugene;
    • Cavender, Matthew A.;
    • Mosenzon, Ofri;
    • Steg, Ph. Gabriel;
    • Davidson, Jaime A.;
    • Nicolau, Jose C.;
    • Corbalan, Ramon;
    • Hirshberg, Boaz;
    • Frederich, Robert;
    • KyungAh Im;
    • Umez-Eronini, Amarachi A.;
    • He, Ping;
    • McGuire, Darren K.;
    • Leiter, Lawrence A.;
    • Raz, Itamar;
    • Scirica, Benjamin M.
    Publication type:
    Article
    29

    Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model.

    Published in:
    Journal of the American Heart Association, 2018, v. 7, n. 16, p. 1, doi. 10.1161/JAHA.118.009217
    By:
    • Kaasenbrood, Lotte;
    • Bhatt, Deepak L.;
    • Dorresteijn, Jannick A. N.;
    • Wilson, Peter W. F.;
    • D’Agostino Sr., Ralph B.;
    • Massaro, Joseph M.;
    • van der Graaf, Yolanda;
    • Cramer, Maarten J. M.;
    • Kappelle, L. Jaap;
    • de Borst, Gert J.;
    • Steg, Ph. Gabriel;
    • Visseren, Frank L. J.
    Publication type:
    Article
    30
    31

    One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis.

    Published in:
    JAMA: Journal of the American Medical Association, 2007, v. 297, n. 11, p. 1197, doi. 10.1001/jama.297.11.1197
    By:
    • Steg, Ph. Gabriel;
    • Bhatt, Deepak L.;
    • Wilson, Peter W.F.;
    • D'Agostino, Ralph;
    • Ohman, E. Magnus;
    • Röther, Joachim;
    • Liau, Chiau-Suong;
    • Hirsch, Alan T.;
    • Mas, Jean-Louise;
    • Ikeda, Yasou;
    • Pencina, Michael J.;
    • Goto, Shinya
    Publication type:
    Article
    32
    33
    34
    35

    Do patients benefit from omega-3 fatty acids?

    Published in:
    Cardiovascular Research, 2023, v. 119, n. 18, p. 2884, doi. 10.1093/cvr/cvad188
    By:
    • Sherratt, Samuel C R;
    • Mason, R Preston;
    • Libby, Peter;
    • Steg, Ph Gabriel;
    • Bhatt, Deepak L
    Publication type:
    Article
    36
    37
    38

    Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.

    Published in:
    Journal of the American Heart Association, 2023, v. 12, n. 5, p. 1, doi. 10.1161/JAHA.121.026756
    By:
    • Olshansky, Brian;
    • Bhatt, Deepak L.;
    • Miller, Michael;
    • Steg, Ph. Gabriel;
    • Brinton, Eliot A.;
    • Jacobson, Terry A.;
    • Ketchum, Steven B.;
    • Doyle Jr, Ralph T.;
    • Juliano, Rebecca A.;
    • Jiao, Lixia;
    • Kowey, Peter R.;
    • Reiffel, James A.;
    • Tardif, Jean-Claude;
    • Ballantyne, Christie M.;
    • Chung, Mina K.
    Publication type:
    Article
    39
    40

    Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.

    Published in:
    2022
    By:
    • Peterson, Benjamin E.;
    • Bhatt, Deepak L.;
    • Steg, Ph. Gabriel;
    • Miller, Michael;
    • Brinton, Eliot A.;
    • Jacobson, Terry A.;
    • Ketchum, Steven B.;
    • Juliano, Rebecca A.;
    • Jiao, Lixia;
    • Doyle Jr., Ralph T.;
    • Granowitz, Craig;
    • Gibson, C. Michael;
    • Pinto, Duane;
    • Giugliano, Robert P.;
    • Budoff, Matthew J.;
    • Tardif, Jean-Claude;
    • Verma, Subodh;
    • Ballantyne, Christie M.;
    • Doyle, Ralph T Jr;
    • REDUCE‐IT Investigators
    Publication type:
    journal article
    41

    HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome.

    Published in:
    2020
    By:
    • Boccara, Franck;
    • Mary-Krause, Murielle;
    • Potard, Valérie;
    • Teiger, Emmanuel;
    • Lang, Sylvie;
    • Hammoudi, Nadjib;
    • Chauvet, Marion;
    • Ederhy, Stéphane;
    • Dufour-Soulat, Laurie;
    • Ancedy, Yann;
    • Nhan, Pascal;
    • Adavane, Saroumadi;
    • Steg, Ph. Gabriel;
    • Funck-Brentano, Christian;
    • Costagliola, Dominique;
    • Cohen, Ariel;
    • PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †
    Publication type:
    journal article
    42
    43
    44

    Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis.

    Published in:
    JAMA: Journal of the American Medical Association, 2010, v. 304, n. 12, p. 1350, doi. 10.1001/jama.2010.1322
    By:
    • Bhatt, Deepak L.;
    • Eagle, Kim A.;
    • Ohman, E. Magnus;
    • Hirsch, Alan T.;
    • Goto, Shinya;
    • Mahoney, Elizabeth M.;
    • Wilson, Peter W. F.;
    • Alberts, Mark J.;
    • D'Agostino, Ralph;
    • Chiau-Suong Liau;
    • Mas, Jean-Louis;
    • Röther, Joachim;
    • Smith Jr., Sidney C.;
    • Salette, Geneviève;
    • Contant, Charles F.;
    • Massaro, Joseph M.;
    • Steg, Ph. Gabriel
    Publication type:
    Article
    45
    46

    Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting

    Published in:
    Clinical Cardiology, 2016, v. 39, n. 10, p. 555, doi. 10.1002/clc.22572
    By:
    • Cannon, Christopher P.;
    • Gropper, Savion;
    • Bhatt, Deepak L.;
    • Ellis, Stephen G.;
    • Kimura, Takeshi;
    • Lip, Gregory Y.H.;
    • Steg, Ph. Gabriel;
    • Berg, Jurriën M.;
    • Manassie, Jenny;
    • Kreuzer, Jörg;
    • Blatchford, Jon;
    • Massaro, Joseph M.;
    • Brueckmann, Martina;
    • Ferreiros Ripoll, Ernesto;
    • Oldgren, Jonas;
    • Hohnloser, Stefan H.
    Publication type:
    Article
    47
    48
    49
    50